PERIORBITAL FAT ATROPHY

This adverse event was reported 43 times

These drugs are most commonly taken by patients reporting PERIORBITAL FAT ATROPHY:

# Drug Count
0 BIMATOPROST 23
1 TRAVOPROST 5
2 ADALIMUMAB 1
3 ASPIRIN 1
4 ASPIRIN 325 MG 1
5 ASPIRIN 81 MG 1
6 ATENOLOL 1
7 CALCIUM 1
8 CETIRIZINE HYDROCHLORIDE 1
9 CLONIDINE 1
See all common drugs associated with PERIORBITAL FAT ATROPHY

PERIORBITAL FAT ATROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LATANOPROSTENE BUNOD 1 0.0009
1 BIMATOPROST 23 0.0008
2 TRAVOPROST 5 0.0006
3 PERFLUOROHEXYLOCTANE 1 0.0004
4 SELENIUM 1 0.0002
5 IVERMECTIN 1 0.0002
6 POLYETHYLENE GLYCOL 400 1 0.0001
7 PROGESTERONE 1 0.0000
8 PAROXETINE HYDROCHLORIDE HEMIHYDRATE 1 0.0000
9 PAROXETINE HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with PERIORBITAL FAT ATROPHY

PERIORBITAL FAT ATROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Semifluorinated Alkane [EPC] 1 0.0004
1 Cytolytic Agent [EPC] 1 0.0004
2 Prostaglandin Analog [EPC] 29 0.0003
3 Antiparasitic [EPC] 1 0.0002
4 Pediculicide [EPC] 1 0.0002
5 Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] 1 0.0002
6 Progesterone [EPC] 1 0.0000
7 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
8 5-alpha Reductase Inhibitor [EPC] 1 0.0000
9 Calcium [EPC] 1 0.0000
See all drug classes enriched for association with PERIORBITAL FAT ATROPHY